Browsing Tag
Frazier Life Sciences
2 posts
Fulcrum Therapeutics agrees reverse merger with Slate Medicines and $270m dividend
Fulcrum's $270m dividend and 5% stub hand Slate a Nasdaq listing, but SLTE-1009's PACAP bet must beat CGRP incumbents to justify a $350m valuation.
Furoscix ReadyFlow approval triggers $45m bill as MannKind Corporation raises fresh capital
MannKind Corporation wins Furoscix ReadyFlow approval and raises $50 million as a $45 million acquisition payment reshapes the outlook.